Emily White
About Emily White
Emily White serves as the Senior Vice President of Sales & Marketing at Phase2, where she has worked since 2019. With extensive experience in marketing and sales across various companies, she has played a key role in advancing human-centric strategies in US health systems.
Current Role at Phase2
Emily White serves as the Senior Vice President of Sales & Marketing at Phase2. She has held this position since 2019, working remotely from Raleigh, North Carolina. In her current role, she focuses on driving sales strategies and marketing initiatives that align with the company's objectives. Her leadership is pivotal in enhancing the company's market presence and fostering client relationships.
Previous Experience at Phase2
Prior to her current role, Emily White was the Senior Vice President of Marketing at Phase2 from 2020 to 2024. She also held the position of Vice President of Marketing at the same company from 2019 to 2020. During her tenure, she contributed to various marketing strategies and initiatives that supported the company's growth and client engagement.
Professional Background
Emily White has a diverse professional background in sales and marketing across various industries. She worked at CMD as the Technology Group Account Director for one year in 2017-2018. Additionally, she served as Executive Vice President at Basalt for six months in 2019 and as Vice President of Sales & Marketing at Basalt from 2018 to 2019. Her experience also includes a role as Vice President at Edelman from 2015 to 2017.
Education and Expertise
Emily White holds a Bachelor of Arts in Mass Communication/Media Studies from Virginia Wesleyan University, which she completed from 1997 to 2001. She also earned a Master of Arts in Mass Communication/Cinema Television from Regent University between 2002 and 2004. Her academic background supports her expertise in go-to-market strategy, brand management, sales, client service, and market research.
Impact on Health Systems
At Phase2, Emily White has played a significant role in transforming U.S. health systems through the implementation of advanced human-centric strategies and technology development. Her contributions have focused on enhancing operational efficiencies and improving client outcomes within the healthcare sector.